From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 1, 2026
CautionEmerging evidence
What is happening. Chromium may enhance insulin signaling and glucose metabolism, adding to tirzepatide's glucose-lowering effect.
Mechanism. Chromium may potentiate insulin signaling. Tirzepatide lowers glucose through GIP/GLP-1 receptor activation.
Recommendation. Low-dose chromium in a multivitamin is usually low risk. Use caution with high-dose chromium supplements and monitor glucose when starting or changing dose.
Stack Score
How it moves the number.
Effect on the composite score
If both Chromium and Tirzepatide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.